| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.033 | 0.5 |